- Advertised equivalent
- $120/month
- Minimum duration
- 2.5 months
- Checkout minimum
- $299 total
- Included supply
- 1,000 mg vial, syringes, shipping and unlimited consultations
- Clinical process
- Online intake and provider review described
The minimum matters more than the headline
TRT Nation's NAD+ advertisement combines a rounded $120 monthly equivalent with a 2.5-month minimum purchase. The checkout page states the actual listed package total as $299. We use that figure rather than multiplying the rounded headline, because a reader comparing initial payments needs the stated purchase amount and the period it covers.
The checkout identifies a 1,000 mg vial, syringes, shipping and unlimited consultations as included. Confirm the selected offer after state and clinical eligibility checks, and ask whether later refills use the same package terms. The initial listing does not guarantee unchanged renewal pricing or an appropriate prescription for every applicant.
Establish the actual injection order
The checkout's vial and syringe description identifies an injectable supply, while the wider catalog places NAD+ beside other anti-aging therapies. The 1,000 mg amount is public, but the prescriber should still confirm route, concentration, liquid volume and pharmacy for the actual order. The stated commercial period does not replace those details or establish an opened container's usable life.
We do not derive administration frequency or a dose from the price. Doing so would turn a budget comparison into an unsupported treatment schedule. The clinician's plan and pharmacy label determine use; the invoice should explain what supply is being paid for.
Why container dates affect the economics
A multi-month purchase can involve one shipment, multiple containers or a different fulfillment arrangement. Ask how the supplied medication's usable dates align with the intended plan and whether containers arrive together or in stages. The answer determines whether the apparent minimum-period value is practical for the prescribed use.
Do not assume that unopened and opened containers share the same deadline. The pharmacy should explain each applicable limit. If the prescription changes, leftover medication may not be transferable to a future plan, which is another reason to clarify the order before committing to a longer period.
The evaluation and follow-up questions
TRT Nation's catalog FAQ says peptide therapy does not require blood work. Since NAD+ is a coenzyme and a patient's circumstances vary, that broad category statement should not replace a specific clinical discussion. Ask what assessment is appropriate, whether any additional tests are recommended and which charges would be separate.
Also request the follow-up process. Knowing when to contact a clinician, how to report a problem and how a refill is reviewed gives the patient a more concrete picture than a general promise of monitoring. An online intake should be evaluated as part of care, not just a step in checkout.
Who should focus on this offer
This entry is relevant to readers comparing minimum purchase periods with month-to-month subscriptions. A patient comfortable with the proposed clinical plan may view a larger initial commitment differently from someone still exploring whether any prescription is appropriate. Neither circumstance can be resolved by the $120 headline alone.
The catalog's energy and cognitive statements are not a forecast for an individual. Our conclusion is financial and operational: confirm the full invoice, product specification, refill rules and cancellation cutoff before comparing the offer with alternatives. A low monthly equivalent is useful information only when the commitment and the uncertainty of benefit remain visible beside it.
Useful distinctions
- Checkout states the actual $299 package total
- Vial amount, syringes, shipping and consultations are listed
- Minimum purchase period is explicit
Limitations to weigh
- Monthly equivalent is not the initial payment
- Concentration, usable dates and renewal terms still need confirmation
- A catalog claim does not establish clinical effectiveness
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.